Titles

  • Head of the cancer research department, Centre de recherche du CHUM
  • Scientific director, Montreal Cancer Institute
  • Professor
  • Researcher at CRCHUM
  • Research member at the Montreal Cancer Institute

Research Angle

Cancer et aging

Laboratory Team

Postdoctoral :

  • Nhung Vuong
  • Jordan Guillon

Students :

  • Marie Camille Rowell
  • Stéphane Lopes
  • Paloma Kalegari
  • Ana Fernandez
  • Sebastian Igelmann
  • Tony Buffard

Recent Publications

  1. Hébert A, Parisotto M, Rowell MC, Doré A, Fernandez Ruiz A, Lefrançois G, Kalegari P, Ferbeyre G*, Schmitzer AR*. Phenylethynylbenzyl-modified biguanides inhibit pancreatic cancer tumor growth. Sci Rep. 2021 May 10;11(1):9854. *corresponding authors
  2. Saint-Germain E, et al. Phosphorylation of SOCS1 inhibits the SOCS1-p53 tumor suppressor axis. Cancer Res. 2019 79(13):3306-3319.
  3. Deschênes-Simard X, et al. Circumventing senescence is associated with stem cell properties and metformin sensitivity. Aging Cell. 2019 8(2):e12889.
  4. Lessard F, et al. Senescence-associated ribosome biogenesis defects contributes to cell cycle arrest through the Rb pathway. Nature Cell Biol 2018 Jul;20(7):789-799.
  5. Saint-Germain E, et al. SOCS1 regulates senescence and ferroptosis by modulating the expression of p53 target genes. Aging (Albany NY). 2017 Oct 28. 9(10): 2137-2162.

Pubmed Page

https://pubmed.ncbi.nlm.nih.gov/?term=ferbeyre&sort=pubdate&size=100&filter=simsearch2.ffrft

Email address for application

g.ferbeyre@umontreal.ca

Biography

Dr. Gerardo Ferbeyre graduated from medical school at the University of Havana, Cuba. He then obtained a Ph.D. from the Université de Montréal in 1996. He was a postdoctoral researcher in New York at the Cold Spring Harbor Laboratory where he discovered new mechanisms of tumor suppression. His laboratory is interested in cell signaling and cancer and in the discovery of new anti-cancer therapies.